The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease
Abstract
OBJECTIVE: The aim of this randomized controlled study was to investigate the efficacy of ciprofloxacin compared with mesalazine in treating active Crohn's disease. METHODS: Patients with a mild to moderate flare-up of Crohn's disease (mean Crohn's Disease Activity Index [CDAI]; 217; range, 160-305) were randomized to receive ciprofloxacin 1 g/day or Pentasa 4 g/day for 6 wk. Complete remission was defined at wk 6 as a CDAI < or = 150 associated with a decrease (delta) in CDAI > 75. Partial remission was defined as a CDAI < or = 150 with 50 < delta CDAI < 75 or a CDAI > 150 with delta CDAI > 50 at wk 6. Group sequential procedure with triangular continuation regions was used to monitor the trial through the difference in complete remission rates, every 20 patients included. RESULTS: Inclusion of patients was stopped at the second step, i.e., after 40 inclusions, with the conclusion of no difference in complete remission rates between ciprofloxacin- and Pentasa-treated groups. Among the 18 patients taking ciprofloxacin, two decided to stop treatment during the trial and three were considered as treatment failures because of deterioration at wk 3. Among the 22 patients taking mesalazine, one patient was lost to follow-up and eight patients were considered as treatment failures. Complete remission was observed in 10 patients (56%) treated with ciprofloxacin and 12 patients (55%) treated with mesalazine and partial remission was observed in three and one patient, respectively. CONCLUSIONS: This study suggests that ciprofloxacin 1 g/day is as effective as mesalazine 4 g/day in treating mild to moderate flare-up of Crohn's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fluoroquinolone Antimicrobial Agents
Hooper, D. C., & Wolfson, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102073240606 · Cited by 548
The Design and Analysis of Sequential Clinical Trials.
Whitehead, J. (1997) · Biometrics · doi:10.2307/2533535 · Cited by 516
Infections of the Gastrointestinal Tract
Wong, E. S. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530280083052 · Cited by 512
Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial
Singleton, J. W., Hanauer, S. B., Gitnick, G. L., Peppercorn, M. A., Robinson, M. G., Wruble, L. D., & Krawitt, E. L. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90337-c · Cited by 357
Liu, Y., Van Kruiningen, H. J., West, A. B., Cartun, R. W., Cortot, A., & Colombel, J.-F. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90687-8 · Cited by 291
Self-citationAmbrose, N. S., Johnson, M., Burdon, D. W., & Keighley, M. R. B. (1984) · Journal of British Surgery · doi:10.1002/bjs.1800710821 · Cited by 195
Group Sequential Clinical Trials with Triangular Continuation Regions
Whitehead, J., & Stratton, I. (1983) · Biometrics · doi:10.2307/2530822 · Cited by 189
Boirivant, M., Leoni, M., Tariciotti, D., Fais, S., Squarcia, O., & Pallone, F. (1988) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198808000-00011 · Cited by 170
Brumfitt, W., Franklin, I., Grady, D., Hamilton-Miller, J. M., & Iliffe, A. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.5.757 · Cited by 166
National Cooperative Crohn's Disease Study: Study design and conduct of the study
Winship, D. H., Summers, R. W., Singleton, J. W., Best, W. R., Becktel, J. M., Lenk, L. F., & Kern, F. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90383-4 · Cited by 144
Cited by
Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A.-L., Barnich, N., Bringer, M.-A., Swidsinski, A., Beaugerie, L., & Colombel, J.-F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.061 · Cited by 1,566
Self-citationDignass, A., Van Assche, G., Lindsay, J. O., Lémann, M., Söderholm, J., Colombel, J. F., Danese, S., D'Hoore, A., Gassull, M., Gomollón, F., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.12.002 · Cited by 1,498
Self-citationACG Clinical Guideline: Management of Crohn's Disease in Adults
Lichtenstein, G. R., Loftus, E. V., Isaacs, K. L., Regueiro, M. D., Gerson, L. B., & Sands, B. E. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2018.27 · Cited by 1,421
Guidelines for the management of inflammatory bowel disease in adults
Mowat, C., Cole, A., Windsor, A., Ahmad, T., Arnott, I., Driscoll, R., Mitton, S., Orchard, T., Rutter, M., Younge, L., et al. (2011) · Gut · doi:10.1136/gut.2010.224154 · Cited by 1,419
Management of Crohn's Disease in Adults
Lichtenstein, G. R., Hanauer, S. B., & Sandborn, W. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.168 · Cited by 1,173
Metadata
- Authors
- Colombel, J.
- Venue
- The American Journal of Gastroenterology
- Published
- 1999-03
- Volume
- 94
- Issue
- 3
- Pages
- 674-678
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2978265545
- Cited by
- 254
- References
- 17
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. https://app.cochat.ai/papers/10.1016/s0002-9270(98)00816-8
- The paper
- Colombel, J. (1999). A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. The American Journal of Gastroenterology. https://doi.org/10.1016/s0002-9270(98)00816-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.